4
Changes in Ownership
Niagen Bioscience, Inc. Filed Acc 0001628280-22-006443
CEO bought 25,000 shares at $2.16 ($54,000)
From the SEC's structured data for this filing
Trades in this filing
Fried Robert N · CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-03-16 | Purchase : show line 1 in the form | +25,000 | $2.16 | $54,000 | 88,001 | I |
| Open-market purchases · 25,000 sh · avg $2.16 · $54,000 | ||||||
Loading xslF345X03/wf-form4_164747330857843.xml…